Literature DB >> 11375792

Clinical and molecular analysis of three Mexican families with Pendred's syndrome.

O Gonzalez Trevino1, O Karamanoglu Arseven, C J Ceballos, V I Vives, R C Ramirez, V V Gomez, G Medeiros-Neto, P Kopp.   

Abstract

BACKGROUND: The autosomal recessive Pendred's syndrome is defined by congenital sensorineural deafness, goiter, and impaired iodide organification. It is caused by mutations in the Pendred's syndrome (PDS) gene that encodes pendrin, a chloride/iodide transporter expressed in the thyroid, the inner ear, and the kidney.
OBJECTIVE: To perform a detailed clinical and molecular analysis of patients with Pendred's syndrome from four patients from three unrelated Mexican families.
METHODS: Thyroid function tests, perchlorate test, thyroid scintigraphy, audiometry, computer tomography and magnetic resonance imaging were performed in all affected individuals. Haplotype analyses were performed using microsatellite markers flanking the PDS locus, and the PDS gene was submitted to direct sequence analysis.
RESULTS: All patients presented with sensorineural deafness, Mondini malformations of the cochlea, an enlarged vestibular aqueduct, goiter, and a positive perchlorate test. Two patients were hypothyroid, two individuals were euthyroid. Sequence analysis revealed a complex homozygous deletion/insertion mutation at the end of exon 4 in the index patient of family 1 resulting in a premature stop codon at position 138. In family 2, the affected individuals were compound heterozygous for a splice acceptor mutation (IVS2 -1G>A) and a 1231G>C transversion substituting alanine 411 by proline (A411P). In family 3, the index patient was found to be homozygous for a transversion 412G>T in exon 4 replacing valine 138 by phenylalanine (V138F).
CONCLUSIONS: All patients included in this study presented with the classic Pendred syndrome triad and molecular analysis revealed pendrin mutations as the underlying cause. The identification of three novel mutations, one of them of complex structure, expands the spectrum of mutations in the PDS gene and emphasizes that they display marked allelic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375792     DOI: 10.1530/eje.0.1440585

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  10 in total

1.  Atrophic thyroid follicles and inner ear defects reminiscent of cochlear hypothyroidism in Slc26a4-related deafness.

Authors:  Amiel A Dror; Danielle R Lenz; Shaked Shivatzki; Keren Cohen; Osnat Ashur-Fabian; Karen B Avraham
Journal:  Mamm Genome       Date:  2014-04-24       Impact factor: 2.957

2.  Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness.

Authors:  H-J Park; S Shaukat; X-Z Liu; S H Hahn; S Naz; M Ghosh; H-N Kim; S-K Moon; S Abe; K Tukamoto; S Riazuddin; M Kabra; R Erdenetungalag; J Radnaabazar; S Khan; A Pandya; S-I Usami; W E Nance; E R Wilcox; S Riazuddin; A J Griffith
Journal:  J Med Genet       Date:  2003-04       Impact factor: 6.318

3.  Absence of primary hypothyroidism and goiter in Slc26a4 (-/-) mice fed on a low iodine diet.

Authors:  D Calebiro; P Porazzi; M Bonomi; S Lisi; A Grindati; D De Nittis; L Fugazzola; M Marinò; G Bottà; L Persani
Journal:  J Endocrinol Invest       Date:  2010-09-09       Impact factor: 4.256

Review 4.  Genetic etiology of non-syndromic hearing loss in Latin America.

Authors:  Karina Lezirovitz; Regina Célia Mingroni-Netto
Journal:  Hum Genet       Date:  2021-10-15       Impact factor: 4.132

5.  Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct.

Authors:  F Bogazzi; D Russo; F Raggi; F Ultimieri; S Berrettini; F Forli; L Grasso; C Ceccarelli; S Mariotti; A Pinchera; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

6.  Pendred syndrome in two Galician families: insights into clinical phenotypes through cellular, genetic, and molecular studies.

Authors:  Fernando Palos; María E R García-Rendueles; David Araujo-Vilar; Maria Jesús Obregon; Rosa Maria Calvo; Jose Cameselle-Teijeiro; Susana B Bravo; Oscar Perez-Guerra; Lourdes Loidi; Barbara Czarnocka; Paula Alvarez; Samuel Refetoff; Lourdes Dominguez-Gerpe; Clara V Alvarez; Joaquin Lado-Abeal
Journal:  J Clin Endocrinol Metab       Date:  2007-10-16       Impact factor: 5.958

7.  Novel pathogenic variants underlie SLC26A4-related hearing loss in a multiethnic cohort.

Authors:  Filiz Basak Cengiz; Rasim Yilmazer; Levent Olgun; Levent Sennaroglu; Tayfun Kirazli; Hudaver Alper; Yuksel Olgun; Armagan Incesulu; Tahir Atik; Fabiola Huesca-Hernandez; Juan Domínguez-Aburto; Garly González-Rosado; Edgar Hernandez-Zamora; Maria de la Luz Arenas-Sordo; Ibis Menendez; Kadir Serkan Orhan; Hakan Avci; Nejat Mahdieh; Mortaza Bonyadi; Joseph Foster; Duygu Duman; Ferda Ozkinay; Susan H Blanton; Guney Bademci; Mustafa Tekin
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2017-08-08       Impact factor: 1.675

Review 8.  Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.

Authors:  Aigerim Bizhanova; Peter Kopp
Journal:  Endocrinology       Date:  2009-02-05       Impact factor: 4.736

Review 9.  The genetic bases for non-syndromic hearing loss among Chinese.

Authors:  Xiao Mei Ouyang; Denise Yan; Hui Jun Yuan; Dai Pu; Li Lin Du; Don Yi Han; Xue Zhong Liu
Journal:  J Hum Genet       Date:  2009-02-06       Impact factor: 3.172

10.  Study on the relationship between the pathogenic mutations of SLC26A4 and CT phenotypes of inner ear in patient with sensorineural hearing loss.

Authors:  Lihua Wu; Yunliang Liu; Jianman Wu; Sheng Chen; Shupin Tang; Yi Jiang; Pu Dai
Journal:  Biosci Rep       Date:  2019-03-22       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.